Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chromadex Corp CS
(NQ:
CDXC
)
3.250
+0.080 (+2.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Chromadex Corp CS
< Previous
1
2
3
Next >
ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China
May 19, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®
May 17, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Corporation Reports First Quarter 2022 Financial Results
May 12, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
April 29, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors
April 22, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World
April 14, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio
April 06, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Announces Issuance of Additional New U.S. Continuation Patent, Further Protecting Future Innovations
March 16, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report Fourth Quarter 2021 Financial Results on Wednesday, March 9, 2022
February 22, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Announces Issuance of New U.S. Continuation Patent, Expanding Intellectual Property Portfolio for Nicotinamide Riboside
February 09, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex External Research Program (CERP™) Celebrates 100 Peer-Reviewed Published Studies on Niagen® and Other Ingredients
January 31, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Announces Results of New Pilot Clinical Trial Showing Anti-Inflammatory Effects of Nicotinamide Riboside (NR) Supplementation
January 25, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex and Designs for Health Partner for New Product Development on Niagen®
January 20, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Corporation Reports Third Quarter 2021 Financial Results
November 03, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Shares Findings from First Clinical Study on Nicotinamide Riboside (NR) in Children, Highlighting Improvements for Prematurely Aging Patients with Ataxia-Telangiectasia (AT)
October 18, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report Third Quarter 2021 Financial Results on Wednesday, Nov. 3, 2021
October 13, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Comments on Jury Award Against Elysium Health and Reiterates Plans for Growth
October 01, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland China
September 29, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP™)
September 20, 2021
From
ChromaDex Corporation.
Via
Business Wire
ChromaDex Continues to Defend Strong Intellectual Property Portfolio and Plans to Appeal Judge’s Ruling in Patent Infringement Lawsuit
September 15, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Corporation Reports Second Quarter 2021 Financial Results
August 03, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
July 20, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Shares Research Findings from the ChromaDex External Research Program (CERP™)
June 16, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex and Walmart Launch Tru Niagen® in 3,800 Walmart Stores Across the United States
June 07, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Corporation Reports First Quarter 2021 Financial Results
May 06, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex and Ro Partner for New Product Development
May 04, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Present at Benzinga’s Global Small Cap Conference on May 13, 2021
May 03, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
April 29, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex and Health & Happiness (H&H) Group Announce Supply Agreement for Niagen®
April 28, 2021
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Appoints Fadi Karam as Chief Marketing Officer
April 19, 2021
From
ChromaDex Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.